KalVista Pharmaceuticals, Inc. (KALV) Social Stream
KalVista Pharmaceuticals Inc (KALV) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering KALV.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 16 months, KALV's average price target has gone up $20.15.
KALV reports an average of 242.69% for its upside potential over the past 26 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
KALV Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
KALV's average broker recommendation rating improved by 0.43 over the prior 151 days.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- KALV has a greater upside potential (average analyst target price relative to current price) than 530.64% of all US stocks.
- KALV has a higher average analyst price target than 527.32% of stocks in the small market cap category.
- In terms of how KalVista Pharmaceuticals Inc fares relative to stocks in the small market cap category, note that its number of analysts covering the stock is higher than 510.12% of that group.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, KalVista Pharmaceuticals Inc's variance in analysts' estimates is lower than -57.75% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to KalVista Pharmaceuticals Inc are KALA, JANX, and IVA.
Make investment decisions regarding KALV using the data that counts. Try POWR Ratings for free.